Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Glaxo down as Unilever refuses to up consumer bid

Thu, 20th Jan 2022 09:01

(Alliance News) - The FTSE 100 was failing to build on recent gains early Thursday, with GlaxoSmithKline dragging on the index amid disappointment that Unilever has refused to raise its bid for the GSK consumer unit.

The FTSE 100 index was down 8.11 points, or 0.1%, at 7,581.55 early Thursday. The mid-cap FTSE 250 index was up 24.50 points, or 0.1%, at 22,679.52. The AIM All-Share index was down just 0.19 point at 1,149.30.

The Cboe UK 100 index was down 0.1% at 752.68. The Cboe 250 was up 0.1% at 20,333.79, and the Cboe Small Companies down 0.1% at 15,771.02.

In mainland Europe, the CAC 40 in Paris was down 0.4%, while the DAX 40 in Frankfurt was down 0.2% early Thursday.

GlaxoSmithKline was at the bottom of London's FTSE 100 index, down 1.9%, after Unilever late Wednesday said it will not lift its bid for GlaxoSmithKline's consumer unit above the current GBP50 billion offer.

The FTSE 100-listed consumer goods firm said it has seen a set of financial assumptions on the consumer healthcare business, outlined by current owners GSK. Unilever said the numbers do not "change our view on fundamental value".

Unilever on Wednesday added it is "committed to maintaining strict financial discipline" and ensuring any acquisitions can create value for shareholders.

Unilever shares were up 1.2% early Thursday. The stock had tumbled 7.0% on Monday and a further 4.0% on Tuesday over worries it could end up paying too much for the GSK consumer unit.

Associated British Foods fell 1.6%. The firm said its outlook remains unchanged as input cost inflation has been offset by sales growth and strong margins at fast-fashion retailer Primark.

Total sales for the 16 weeks to January 8 stood at GBP5.57 billion, up 16% on a year ago. Driving the growth was AB Foods' retail arm, which houses Primark, where sales jumped 32% to GBP2.67 billion.

Grocery, Sugar, Agriculture and Ingredients revenue rose 5% in total to GBP2.90 billion.

"All businesses have experienced inflationary pressures in raw materials, commodities, supply chain and energy. Margins in Grocery and Ingredients were impacted where sales price actions have lagged the effects of input cost inflation," said AB Foods.

In Retail, however, operating profit margin was ahead of expectations and is expected to be over 10% at the half-year. Inflationary pressures were broadly mitigated by a favourable US dollar exchange rate and a reduction in store operating costs and overheads. AB Foods added that supply chain pressures have alleviated somewhat.

Taking all of its units into consideration, AB Foods said its outlook is unchanged.

At the top of the FTSE 100 was Burberry, up 2.1% and extending Wednesday's 6.3% gain on an upbeat trading update.

In the FTSE 250, Premier Foods rose 4.9% after lifting profit forecasts following a better-than-expected financial third quarter.

Sales in the 13 weeks to January 1 were up down 1.8% on a year ago but up 7.0% on a two-year basis. The firm said it significant outperformed the market and its Mr Kipling cake brand had its "biggest ever" Christmas.

"The strong momentum from the first half of the year continued into the key Q3 trading period, with our brands growing by 11.3% compared to two years ago. This was well ahead of the market across all our categories and resulted in very encouraging share gains," said Chief Executive Alex Whitehouse.

After "three strong quarters of trading", Premier Foods lifted its full-year profit expectations. It expects trading profit of at least GBP145 million and adjusted pretax profit of at least GBP125 million. It noted that current consensus for trading profit is GBP140.7 million and for adjusted pretax profit GBP119.3 million.

Spirent Communications was up 4.7% after saying it expects to delivery full-year adjusted operating profit slightly ahead of market consensus, which it placed as USD116 million.

Deliveroo rose 4.3% on a strong finish to 2021, with fourth-quarter orders up 42%.

Gross transaction value in the final three months of 2021 stood at GBP1.73 billion, up 33% on a year before. A 42% rise in orders to 80.8 million helped to offset a 7% dip in gross transaction value per order to GBP21.4.

In the UK, gross transaction value rose 35% to GBP945 million, with orders up 41% at 40.4 million but gross transaction value per order down 4% at GBP23.4.

For 2021 as a whole, gross transaction value rose 67% to GBP6.62 billion on a reported basis. At constant currencies, gross transaction value rose 70%, at the top end of guidance for 60% to 70% growth.

In Asia on Thursday, the Japanese Nikkei 225 index ended up 1.1%. In China, the Shanghai Composite ended down 0.1%, while the Hang Seng index in Hong Kong soared 3.4%. The S&P/ASX 200 in Sydney rose 0.1%.

China further reduced bank lending costs Thursday in the latest move to boost its stuttering economy, providing some much-needed support to the country's beleaguered developers.

The People's Bank of China said it lowered the one-year loan prime rate to 3.7% from 3.8% in December.

It had reduced the LPR – which guides how much interest commercial banks charge to corporate borrowers – in December, for the first time in 20 months, as the economy was threatened by the real estate crisis and coronavirus flare-ups.

Property firm shares and bonds surged on the fresh rate cut.

"The rate cut together with the global easing in yields and stories that Chinese regulators are considering measures to support struggling developers have supported Asian equity sentiment this morning," said Danske Bank.

Sterling was quoted at USD1.3631 early Thursday, flat on USD1.3630 at the London equities close on Wednesday.

The euro traded at USD1.1356, firming on USD1.1345 late Wednesday. Against the yen, the dollar rose to JPY114.36 versus JPY114.25.

Gold was quoted at USD1,839.91 an ounce early Thursday, flat versus USD1,840.20 on Wednesday. Brent oil was trading at USD87.78 a barrel, easing from USD88.68 late Wednesday.

The economic events calendar on Thursday has eurozone inflation readings at 1000 GMT and the latest US jobless claims numbers at 1330 GMT.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.